IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia
This study has been completed.
Sponsor:
Sumitomo Dainippon Pharma Co., Ltd.
Information provided by (Responsible Party):
Sumitomo Dainippon Pharma Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01614912
First received: June 6, 2012
Last updated: June 30, 2015
Last verified: June 2015
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | No date given |
| Primary Completion Date: | May 2015 (Final data collection date for primary outcome measure) |